S&P 500's Best Dividend Aristocrats

10:04pm, Wednesday, 30'th Nov 2022 The Motley Fool
Investors looking for stability and payout growth should look closer at Dividend Aristocrat stocks.

3 Top Dividend Kings to Buy for the Long Haul

01:05pm, Wednesday, 30'th Nov 2022 The Motley Fool
Dividend stocks are an easy option to boost income.

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

02:00pm, Monday, 28'th Nov 2022 Zacks Investment Research
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income

01:53pm, Sunday, 27'th Nov 2022 The Motley Fool
Dividend stocks are a great way to protect against a downturn and these are the cream of the crop.

Is This Stock-Split Stock a Buy For 2023?

03:00pm, Saturday, 26'th Nov 2022 The Motley Fool
Don't buy this company's shares for its recent stock split.

Better Dividend Stock: AbbVie or Viatris?

01:15pm, Saturday, 26'th Nov 2022 The Motley Fool
These pharmaceutical companies are profitable and offer above-average dividends.

Is This Stock-Split Stock a Buy For 2023?

10:00am, Saturday, 26'th Nov 2022
Don't buy this company's shares for its recent stock split.
Some of the world's most successful investors made big bets on these dividend payers recently.
We believe Intuitive Surgical stock is currently a better pick than Abbott stock, given its better prospects. Although Abbott is trading at a comparatively lower valuation of 4.1x trailing revenues vs
Some of the world's most successful investors made big bets on these dividend payers recently.
Abbott is a market leader in medical device businesses such as vascular care and diabetes care. It also leads in the in-vitro diagnostic market. The likely decline of COVID testing heavily impacted th
This is a stock that rewards long-term investors through continual dividend increases.

AbbVie Boosts Its Dividend: Is the Dividend King a Buy?

10:20am, Wednesday, 23'rd Nov 2022 The Motley Fool
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE